Prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.
Concomitant use of adequate virostatic agents should be considered.
Composition: Cytomegalovirus Immunoglobulin human 100 IU/ml
